awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35760136-F5F40D21-D6C1-44DE-977C-061AADEA480D
Q35760136-F5F40D21-D6C1-44DE-977C-061AADEA480D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35760136-F5F40D21-D6C1-44DE-977C-061AADEA480D
Prediction of major clinical response (ACR50) to infliximab in psoriatic arthritis refractory to methotrexate.
P2860
Q35760136-F5F40D21-D6C1-44DE-977C-061AADEA480D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35760136-F5F40D21-D6C1-44DE-977C-061AADEA480D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e332a7da7b2aa89e85671b9efc74e455186167f5
P2860
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.